MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Cash Flow
NASDAQ:MREO - Nasdaq - US5894921072 - ADR - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.65M | -36.09M | 14.24M | -166.45M | -41.12M | |||
| Depreciation Amortization | 847.00K | 730.00K | 640.00K | 1.60M | 1.58M | |||
| Change In Working Capital | 607.00K | 290.00K | 980.00K | 7.02M | -6.60M | |||
| Interest Paid | 711.00K | 0.00 | 0.00 | 2.90M | 1.74M | |||
| Taxes Paid | -1.07M | 1.53M | -2.83M | -10.43M | -1.07M | |||
| Other non cash items | 15.56M | -3.75M | -21.10M | 129.49M | 210.00K | |||
| OPERATING CASH FLOW | -17.63M | -38.82M | -5.24M | -28.34M | -45.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -10.00K | -540.00K | -20.00K | -20.00K | |||
| Other Investing Activity | 1.29M | 1.51M | 110.00K | 1.51M | 43.32M | |||
| INVESTING CASH FLOW | 1.29M | 1.50M | -420.00K | 1.50M | 43.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.17M | -940.00K | -690.00K | 22.49M | -2.21M | |||
| Stock Issued/Repurchased | 9.34M | 0.00 | 78.58M | 20.14M | -1.00M | |||
| Other Financing Activity | -1.07M | 150.00K | -230.00K | -7.89M | -2.50M | |||
| FINANCING CASH FLOW | 5.09M | -780.00K | 77.65M | 34.74M | -5.71M | |||
| Exchange Rate Effect | 15.00K | 150.00K | -1.17M | -770.00K | -350.00K | |||
| CHANGE IN CASH | -11.23M | -37.95M | 70.82M | 7.13M | -8.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.63M | -38.82M | -5.24M | -28.34M | -45.93M | |||
| Capital Expenditure | 0.00 | -10.00K | -540.00K | -20.00K | -20.00K | |||
| FREE CASH FLOW | -17.63M | -38.83M | -5.78M | -28.36M | -45.95M | |||
All data in USD